2015

2015.08.04 Announcement: Reprocell’s project, “Prototype Development of a Large-Scale Production Mechanism of Highly Functional Cardiomyocytes Derived From Human iPS Cells”, has been chosen to receive a Subsidy for Collaborative Projects to Advance the Creation of an Innovative Manufacturing Industry (FY 2015-2016). The subsidy will be added to the income statement as non-operating income.

Announcement: Reprocell’s project, “Prototype Development of a Large-Scale Production Mechanism of Highly Func […]

2015.07.29 Announcement: Diseased neurons derived from iPS cells of Alzheimer’s disease patients Initiation of sales of “ReproNeuro AD-patient”

Diseased neurons derived from iPS cells of Alzheimer’s disease patients Initiation of sales of “ReproNeuro AD- […]

2015.07.22 Announcement: Sales commencement of “ReproNeuro MQ Medium”, a cell culture kit which enables the creation of high-functioning nerve cells derived from human iPS cells

Announcement: sales commencement of “ReproNeuro MQ Medium”, a cell culture kit which enables the creation of h […]

2015.06.30 Stemgent, a ReproCELL Group Company Launches a New High Performance Self-replicative RNA Reprogramming Kit

Stemgent, a ReproCELL Group Company Launches a New High Performance Self-replicative RNA Reprogramming Kit

2015.06.24 ReproCELL Concludes the License Agreement with Keio University for the Exclusive Sale of Disease (Hypertrophic Cardiomyopathy) Type Myocardial Cells Derived from iPS Cells

ReproCELL Concludes the License Agreement with Keio University for the Exclusive Sale of Disease (Hypertrophic […]

2015.06.22 ReproCELL Launches New Culture Medium for High Quality Human Naïve iPS Cells, “ReproNaïve™”

ReproCELL Launches New Culture Medium for High Quality Human Naïve iPS Cells, “ReproNaïve™”

2015.06.08 ReproCELL and SBI Pharmaceuticals Develop Selective Removal Technology of Residual iPS Cells from iPS Derived-differentiated Cells for Regenerative Medicine Through Technological Application of SBI Pharmaceuticals’ 5-ALA

ReproCELL and SBI Pharmaceuticals Develop Selective Removal Technology of Residual iPS Cells from iPS Derived- […]

2015.05.25 ReproCELL Launches Worldwide Distribution Agreement with Nano3D Biosciences, Inc.

ReproCELL Launches Worldwide Distribution Agreement with Nano3D Biosciences, Inc.

2015.04.27 ReproCELL Launches Sales Collaboration with Total Lab Systems Ltd. in New Zealand

ReproCELL Launches Sales Collaboration with Total Lab Systems Ltd. in New Zealand

2015.04.20 Alvetex® 3D cell culture platform reaches new heights with project aboard the international space station (ISS)

Alvetex® 3D cell culture platform reaches new heights with project aboard the international space station (ISS […]